M. Sassi

Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project

Lucio Crinò, Giorgio V. Scagliotti, Serafino Ricci et al. · Journal of Clinical Oncology · 1999 · 366 citations

Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales

F. Roila, Marco Lupattelli, M. Sassi et al. · Annals of Oncology · 1991 · 137 citations

Medicine, Cancer Management, Outcomes Research +9

Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: Results of a multicentric Italian study

Francesco Boccardo, A. Rubagotti, Allison Perrotta et al. · Annals of Oncology · 1994 · 135 citations

Advanced Breast Cancer, Breast Oncology, Medicine +11

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (breast cancer adjuvant chemo-hormone therapy cooperative group) trial

Francesco Boccardo, A. Rubagotti, D. Amoroso et al. · European Journal of Cancer · 1992 · 58 citations

Endocrine Oncology, Breast Oncology, Oncology +7

Etoposideversus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer: Results of a prospective randomized fonicap trial

Riccardo Rosso, Franco Salvati, Andrea Ardizzoni et al. · Cancer · 1990 · 53 citations